Home Newsfeeds Piper Sandler Maintains Neutral on Netflix, Raises Price Target to $270

Piper Sandler Maintains Neutral on Netflix, Raises Price Target to $270

Piper Sandler analyst Thomas Champion maintains Netflix (NASDAQ:NFLX) with a Neutral and raises the price target from $215 to $270.

byBenzinga Newsdesk

October 19, 2022

1 minute read

Piper Sandler analyst Thomas Champion maintains Netflix (NASDAQ:NFLX) with a Neutral and raises the price target from $215 to $270.

Mizuho Maintains Neutral on Camden Prop Trust, Lowers Price Target to $136

By Benzinga Newsdesk

September 19, 7:03 AM

Mizuho analyst Haendel St. Juste maintains Camden Prop Trust (NYSE:CPT) with a Neutral and lowers the price target from $142 to $136.

CPT

Top 3 Industrials Stocks That May Collapse This Month

By Avi Kapoor

May 10, 8:44 AM

As of May 10, 2024, three stocks in the industrials sector could be flashing a real warning to…

AVAV

News

‘You’re Rich, You’re Evil’: Why Elon Musk Doesn’t Get Along With One Of His Children

By Chris Katje

October 8, 2:48 PM

The world’s richest man and CEO of Tesla Inc (NASDAQ: TSLA) and SpaceX, has also made headlines in recent years for the number of children he has fathered. Elon Musk ha

TSLA

MariMed Q2 FY23 Revenue Grows 10.7% YoY, What About Adjusted EBITDA?

By Vuk Zdinjak

August 3, 8:19 AM

MariMed Inc. (OTC: MRMD) (CSE:MRMD) released its financial results for the second quarter ended June 30, 2023, revealing revenue of $36.5 million, an increase of 10.7% compared to $33 million in Q2 2022. Q2 2023 Financial Highlights

CSE:MRMD

Piper Sandler Maintains Neutral on Netflix, Raises Price Target to $270

Related Posts

Mizuho Maintains Neutral on Camden Prop Trust, Lowers Price Target to $136

Top 3 Industrials Stocks That May Collapse This Month

‘You’re Rich, You’re Evil’: Why Elon Musk Doesn’t Get Along With One Of His Children

MariMed Q2 FY23 Revenue Grows 10.7% YoY, What About Adjusted EBITDA?